podcasts Ratings /ratings/en/research-insights/podcasts/2020-01-21-sp-pharma-dose-pharmacy-benefit-manager-industry-in-2020-less-regulatory-overhang-expect-more-consolidations content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

In This List

The S&P Pharma Dose - Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations

COMMENTS

COVID-19 Impact: Key Takeaways From Our Articles

COMMENTS

ESG Concerns In Oil And Gas Sectors Led To A Surge In Downgrade Pressure In January, Which Was Realized By Mid-February

COMMENTS

As European Hotels Grapple With Prolonged Restrictions, Are Operators And Landlords Sharing The Pain?

COMMENTS

Pharma Outlook: Eighth Straight Year Of Credit Deterioration In 2021

Listen: The S&P Pharma Dose - Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations

In this episode of S&P Pharma Dose, Ji Liu, Deep Banerjee and Andy Sookram discuss the annual PBM outlook report along with their view on high-profile issuers UnitedHealth, Cigna, CVS and Rite Aid.

Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back